Clinical Trial Update: Study Assessing Safety and Tolerability of AZD8931 Alone or in Combination With Paclitaxel in Japanese Patients. [Phase 1]

View source ↗

Summary

Phase 1 trial assessing the safety and tolerability of AZD8931 alone or with paclitaxel in Japanese patients with breast cancer and other metastatic cancers has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Cancer

Drugs mentioned

• AZD8931 (AZD8931)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: AstraZeneca | Conditions: Neoplasms, Metastatic Cancer | Phase 1 | Status: COMPLETED